Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
CONTACT US
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
contact us
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
CONTACT US
Have a Project in Mind? Say Hi!
+1 800 123 456 789
+1 800 123 654 987
Mon - Sun: 10am - 10pm
27 Division St, New York,
NY 10002, USA
grido@mail.com
Home
2 Columns + Sidebar
2 Columns + Sidebar
September 12, 2022
Los Angeles Business Journal
BY
admin
Respira Technologies Appoints CEO
September 13, 2022
Business Wire
BY
admin
Respira Technologies, Inc. Rebrands as “QNOVIA”; Adopts Qnovia, Inc. as Corporate Name
September 16, 2022
Fierce Pharma
BY
admin
‘Too many Respiras’: Smoking cessation health tech company throws out overused name as it rebrands to Qnovia
September 16, 2022
Fierce Pharma
BY
admin
Too many Respiras’: Smoking cessation health tech company throws out overused name as it rebrands to Qnovia
September 28, 2022
Business Wire
BY
admin
Qnovia, Inc. Raises $17 Million in Series A Funding to Advance Its Inhalable Therapeutics Pipeline
September 28, 2022
HIT Consultant
BY
admin
Qnovia Secures $17M to Advance Inhalable Therapeutics Pipeline
September 28, 2022
Drug Delivery Business
BY
admin
Qnovia raises $17M Series A for inhaled therapeutics pipeline
September 29, 2022
Becker's Hospital Review
BY
admin
Qnovia raises $17M
September 29, 2022
Medtech Strategist
BY
admin
Qnovia: Pocket-Sized Vapor Nebulization
LOAD MORE
#side-panel.side-panel {width: 500px;}#side-panel.side-panel .side-panel_sidebar {padding: 70px 0px 50px 60px;background-color: #FFFFFF;}
Qnovia